Terminology Service < Semantic Lookup Platform

All terms in CHEBI

Label	Id	Description
DG(20:3(8Z,11Z,14Z)/18:0/0:0)	CHEBI_89794
DG(20:3(8Z,11Z,14Z)/16:1(9Z)/0:0)	CHEBI_89795
DG(20:3(8Z,11Z,14Z)/16:0/0:0)	CHEBI_89796
DG(20:3(8Z,11Z,14Z)/18:3(9Z,12Z,15Z)/0:0)	CHEBI_89797
DG(20:3(8Z,11Z,14Z)/20:1(11Z)/0:0)	CHEBI_89798
DG(20:3(8Z,11Z,14Z)/18:3(6Z,9Z,12Z)/0:0)	CHEBI_89799
DG(20:3(8Z,11Z,14Z)/14:0/0:0)	CHEBI_89790
2,6-Dimethylpyrazine	CHEBI_89791
DG(20:3(8Z,11Z,14Z)/18:1(9Z)/0:0)	CHEBI_89792
triphenylacetate salt	CHEBI_75042	[Any organic salt prepared using triphenylacetic acid as the acid component.]
Breo Ellipta	CHEBI_75043	[A mixture composed of vilanterol trifenate and fluticasone furoate (trade name Breo Ellipta) that is used for treatment of bronchospasm associated with chronic obstructive pulmonary disease.]
fluticasone furoate	CHEBI_74899	[A trifluorinated corticosteroid that consists of 6alpha,9-difluoro-11beta,17alpha-dihydroxy-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-16-methyl-3-oxoandrosta-1,4-diene bearing a 2-furoyl substituent at position 17. Used in combination with vilanterol trifenate for treatment of bronchospasm associated with chronic obstructive pulmonary disease.]
vilanterol trifenate	CHEBI_75040	[A triphenylacetate salt obtained by combining vilanterol with one equivalent of triphenylacetic acid. Used in combination with fluticasone furoate for treatment of bronchospasm associated with chronic obstructive pulmonary disease.]
phleomycin	CHEBI_75044	[A mixture of glycopeptide antibiotics originally isolated from the bacterium Streptomyces verticillus whose components all contain a thiazolinylthiazole moiety and can form complexes with redox-active metals such as Co, Cu, and Fe. (Bleomycins are very similar to phleomycins, but have a bithiazole moiety in place of the thiazolinylthiazole moiety).]
phleomycin D1	CHEBI_75046	[A glycopeptide originally isolated from the bacterium Streptomyces verticillus which contains a (4'R)-4',5'-dihydro-2,4'-bi-1,3-thiazole-2',4-diyl moiety with a a 4-guanidylbutylaminocarbonyl group attached to the 4-position of the terminal thiazole ring. Like all phleomycins, phleomycin D1 can form complexes with redox-active metals such as Co, Cu, and Fe.]
mutagen	CHEBI_25435	[An agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.]
dabrafenib	CHEBI_75045	[An organofluorine compound and antineoplastic agent, used as its mesylate salt in treatment of metastatic melanoma.]
B-Raf inhibitor	CHEBI_75047	[A serine/threonine kinase inhibitor that specifically inhibits human mutant serine/threonine kinase (B-Raf)]
bi-1,3-thiazole	CHEBI_48879
glycopeptide	CHEBI_24396	[Any carbohydrate derivative that consists of glycan moieties covalently attached to the side chains of the amino acid residues that constitute the peptide.]